REFERENCES
- Aeby P., Wyss C., Beck H., Griem P., Scheffler H., Goebel C. Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. J. Invest. Dermatol. 2004; 122: 1154–1164, [PUBMED], [INFOTRIEVE], [CSA]
- Ahmad T., Tamboli C. P., Jewell D., Colombel J.-F. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004; 126: 1533–1549, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ahmed S. S., Tan F. K. Identification of novel targets in scleroderma: Update on population studies, cDNA arrays, SNP analysis, and mutations. Curr. Opin. Rheumatol. 2003; 15: 766–771, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Aiba S., Terunuma A., Manome H., Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 1997; 27: 3031–3038, [PUBMED], [INFOTRIEVE], [CSA]
- Alexander W. S., Hilton D. J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 2004; 22: 503–529, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Alexander W. S., Starr R., Fenner J. E., Scott C. L., Handman E., Sprigg N. S., Corbin J. E., Cornish A. L., Darwiche R., Owczarek C. M., Kay T. W., Nicola N. A., Hertzog P. J., Metcalf D., Hilton D. J. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999; 98: 597–608, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Antonopoulus C., Cumberbatch M., Dearman R. J., Daniel R. J., Kimber I, Groves R. W. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 2001; 166: 3672–3677, [CSA]
- Bateman A., Belcourt D., Bennett H., Lazure C., Solomon S. Granulins, a novel class of peptide from leukocytes. Biochem. Biophys. Res. Commun. 1990; 173: 1161–1168, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Begovich A. B., Carlton V. E., Honigberg L. A., Schrodi S. J., Chokkalingam A. P., Alexander H. C., Ardlie K. G., Huang Q., Smith A. M., Spoerke J. M., Conn M. T., Chang M., Chang S. Y., Saiki R. K., Catanese J. J., Leong D. U., Garcia V. E., McAllister L. B., Jeffery D. A., Lee A. T., Batliwalla F., Remmers E., Criswell L. A., Seldin M. F., Kastner D. L., Amos C. I., Sninsky J. J., Gregersen P. K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004; 75: 330–337, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Behrens T. W., Graham R. R., Kyogoku C., Baechler E. C., Ramos P. S., Gillett C., Bauer J., Ortmann W. A., Hippen K. L., Peterson E., Langefeld C. D., Moser K. L., Gaffney P. M., Gregersen P. K. Progress towards understanding the genetic pathogenesis of systemic lupus erythematosus. Novartis Found Symp 2005; 267: 145–60, discussion 160-164[PUBMED], [INFOTRIEVE], [CSA]
- Bender A., Sapp M., Schuler G., Steinmann R. M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human peripheral blood. J. Immunol. Meth. 1996; 196: 121–135, [CROSSREF], [CSA]
- Bilello J. A. The agony and ecstasy of “OMIC” technologies in drug development. Curr. Molec. Med. 2005; 5: 39–52, [CROSSREF], [CSA]
- Boldrick J. C., Alizadeh A. A., Diehn M., Dudoit S., Liu C. L., Belcher C. E., Botstein D., Staudt L. M., Brown P. O., Relman D. A. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. USA. 2002; 99: 972–977, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Boverhof D. R., Tam E., Harney E., Crawford A. S., Kaminski R. B.N. E., Zacharewski T. R. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells. Mol. Pharmacol. 2004; 66: 1662–1670, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brown J. M., Archer A. J., Pfau J. C., Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin. Exp. Immunol. 2003; 131: 415–421, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brown J. M., Schwanke C. M., Pershouse M. A., Pfau J. C., Holian A. Effects of Rottlerin on Silica-Exacerbated Systemic Autoimmune Disease in New Zealand Mixed Mice. Am. J. Physiol. Lung Cell Mol. Physiol 2005, Jul 22; [Epub ahead of print][CSA]
- Brysha M., Zhang J. G., Bertolino P., Corbin J. E., Alexander W. S., Nicola N. A., Hilton D. J., Starr R. Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo. J. Biol. Chem. 2001; 276: 22086–22089, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Burmester G. R., Haupl T. Strategies using functional genomics in rheumatic diseases. Autoimmun. Rev. 2004; 3: 541–549, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cabral G. A., Dove Pettit D. A. Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious disease. J. Neuroimmunol. 1998; 83: 116–123, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Camacho I. A., Nagarkatti M., Nagarkatti P. S. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci 2004; 78: 96–106, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Camacho I. A., Singh N., Hedge V. L., Nagarkatti M., Nagarkatti P. S. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J. Immunol. 2005; 175: 90–103, [PUBMED], [INFOTRIEVE], [CSA]
- Casati Aeby P., Basketter D. A., Cavani A., Gennari A., Gerberick G. F., Griem P., Hartung T., Kimber I., Lepoittevin J.-P., Meade B. J., Pallardy M., Rougier N., Rousset F., Rubinstein G., Sallusto F., Verheyen G. R., Zuang V. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. The report and recommendations of ECVAM workshop 51. ATLA 2005; 33: 47–62, [CSA]
- Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258–261, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chamaillard M., Girardin S. E., Viala J., Philpott D. Nods, Nalps, and Naop: Intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 2003; 5: 581–592, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chaudhary P. M., Roninson I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85–94, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chung W. H., Hung S. I., Hong H. S., Hsih M. S., Yang L. C., Ho H. C., Wu J. Y., Chen Y. T. Nature 2004; 428: 486, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cooper G. S., Miller F. W., Germolec D. R. Occupational exposures and autoimmune diseases. Int. Immunopharmacol. 2002; 2: 303–313, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cox A. L., Skipper J., Chen Y., Henderson R. A., Darrow T. L., Shabanowitz J., Engelhard V. H., Hunt D. F., Slingluff C. L., Jr. Identificaiton of a peptide recognized by five melanoma-specific human cytotoxic T-cell lines. Science 1994; 264: 716–719, [PUBMED], [INFOTRIEVE], [CSA]
- Croker B. P., Gilkeson G., Morel L. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun. 2003; 4: 575–585, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Crow M. K., Wohlgemuth J. Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 2003; 5: 279–287, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cumberbatch M., Dearman R. J., Griffiths C. E. M., Kimber I. Langerhans cell migration. Clin. Exp. Dermatol. 2000; 25: 413–418, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cumberbatch M., Dearman R. J., Kimber I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin 1β for migration. Immunology 1997; 92: 388–395, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Daly A. K, Day C. P., Donaldson P. T. Polymorphisms in immunoregulatory genes. Towards individualized immunosuppressive therapy?. Am. J. Pharmacogenomics 2002; 2: 13–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Davies N. J., Tadesse M. G. T., Vannucci M., Kikuchi H., Trevino V., Sarti D., Dragoni I., Contestabile A., Zanders E., Falciani F. Making sense of molecular signatures in the immune system. Comb. Chem High Throughput Screen 2004; 7: 231–238, [PUBMED], [INFOTRIEVE], [CSA]
- D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. 2000; 112–113: 421–432, [CSA]
- De Groot A. S. Immunome-derived vaccines. Expert Opin. Biol. Ther. 2004; 4: 767–772, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Groot A. S., Martin W. From immunome to vaccine: Epitope mapping and vaccine design tools. Novartis Found. Symp. 2003; 254: 57–72, discussion 72–6, 98–101, 250-252[PUBMED], [INFOTRIEVE], [CSA]
- De Groot A. S., Rappuoli R. Genome-derived vaccines. Expert Rev. Vaccines 2004; 3: 59–76, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Groot A. S., Saint-Aubin C., Bosma A., Sbai H., Rayner J., Martin W. Rapid determination of HLA B*07 ligands from the West Nile virus NY99 genome. Emerg. Infect. Dis 2001; 7: 706–13, [PUBMED], [INFOTRIEVE], [CSA]
- De Groot A. S., Sbai H., Aubin C. S., McMurry J., Martin W. Immuno-informatics: Mining genomes for vaccine components. Immunol. Cell Biol. 2002; 80: 255–269, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Groot A. S., Marcon L., Bishop E. A., Rivera D., Kutzler M., Weiner D., Martin W. HIV vaccine development by computer assisted design: The GAIA vaccine. Vaccine 2005a; 23: 2136–2148, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Groot A. S., McMurry J., Marcon L., Franco J., Rivera D., Kutzler M., Weiner D., Martin B. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 2005b; 23: 2121–2131, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Silva O., Basketter D. A., Barratt M. D., Corsini E., Cronin M. T. D., Das P. K., Degwert J., Enk A., Garrigue J. L., Hauser C., Kimber I., Lepoittevin J-P., Peguet J., Ponec M. Alternative methods for skin sensitisation testing. The report and recommendations of the ECVAM workshop 19. ATLA 1996; 24: 683–705, [CSA]
- Devauchelle V., Marion S., Cagnard N., Mistou S., Falgarone G., Breban M., Letourneur F., Pitaval A., Alibert O., Lucchesi C., Anract P., Hamadouche M., Ayral X., Dougados M., Gidrol X., Fournier C., Chiocchia G. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 2004; 5: 597–608, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dooley M. A., Hogan S. L. Environmental epidemiology and risk factors for autoimmune disease. Curr. Opin. Rheumatol. 2003; 15: 99–103, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cavanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667–673, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Edwards-Smith C. J., Jonsson J. R., Purdie D. M., Sansal A., Shorthouse C., Powell E. E. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999; 30: 526–530, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Encinas J. A., Kuchroo V. K. Mapping and identification of autoimmunity genes. Curr. Opin. Immunol. 2000; 12: 691–697, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Enk A. H., Katz S. I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 1992; 89: 1398–1402, [PUBMED], [INFOTRIEVE], [CSA]
- Espinoza J., Chaiworapongsa T., Romero R., Edwin S., Rathnasabapathy C., Gomez R., Bujold E., Camacho N., Kim Y. M., Hassan S., Blackwell S., Whitty J., Berman S., Redman M., Yoon B. H., Sorokin Y. Antimicrobial peptides in amniotic fluid: Defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J. Matern. Fetal Neonatal Med. 2003; 13: 2–21, [PUBMED], [INFOTRIEVE], [CSA]
- Ezendam J., Staedtler F., Pennings J., Vanderbriel R. J., Pieters R., Boffetta P., Harlemen J. H., Vos J. G. Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats. Environ. Health Perspect. 2004; 112: 782–791, [PUBMED], [INFOTRIEVE], [CSA]
- Fathman C. G., Soares L., Chan S. M., Utz P. J. An array of possibilities for the study of autoimmunity. Nature 2005; 435: 605–611, [PUBMED], [INFOTRIEVE], [CSA]
- Febbraio M., Hajjar D. P., Silverstein R. L. CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 2001; 108: 785–791, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fellay J., Marzolini C., Meaden E. R., Back D. J., Buclin T., Chave J.-P., Decosterd L. A., Furrer H., Opravil M., Pantaleo G., Retelska D., Ruiz L., Schinkel A. H., Vernazza P., Eap C. B., Telenti A. For the Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetics study. The Lancet 2002; 359: 30–36, [CROSSREF], [CSA]
- Ferraccioli G. The possible clinical application of pharmacogenetics in rheumatology. J. Rheumatol. 2003; 30: 2517–2520, [PUBMED], [INFOTRIEVE], [CSA]
- Fisher M. T., Nagarkatti M., Nagarkatti P. S. Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Toxicol. Sci. 2004; 78: 116–124, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Forrest M. S., Lan Q., Hubbard A. E., Zhang L., Vermeulen R., Zhao X., Li G., Wu Y. Y., Shen M., Yin S., Chanock S. J., Rothman N., Smith M. T. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ. Health Perspect. 2005; 113: 801–807, [PUBMED], [INFOTRIEVE], [CSA]
- Foster W. R., Ladics G. S., Glatt C. M. Validation of a minimal transcript biomarker set to differentiate between sensitizers and irritants in the local lymph node assay. Toxicol. Sci. 2004; 78(S-1)A208, [CSA]
- Friedman H., Klwin T. W., Newton C., Daaka Y. Marijuana, receptors and immunomodulation. Adv. Exp. Med. Biol. 1995; 373: 103–113, [PUBMED], [INFOTRIEVE], [CSA]
- Galvani A. P., Novembre J. The evolutionary history of the CCR5-?32 HIV-resistance mutation. Microbes Infect 2005; 7: 302–309, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Geliebter J., Mittelman A., Tiwari R. K. Molecular phenotyping of the immune system by microarray analysis. Cancer Invest. 2003; 21: 293–303, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Genin P., Morin P., Civas A. Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A. J. Virol. 2003; 77: 7113–7119, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Germolec D. R. Sensitivity and predictivity in immunotoxicity testing: Immune endpoints and disease resistance. Toxicol. Lett. 2004; 149: 109–114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gildea L. A., Ryan C. A., Hulette B. C., Dearman R. J., Kimber I., Gerberick G. F. Transcript profiling of T lymphocytes and dendritic cells in a co-culture system using anti-CD3 and allergen activation. J. Toxicol. Cut. Ocular Toxicol. 2004; 23: 277–292, [CROSSREF], [CSA]
- Girardin S. E., Boneca I. G., Viala J., Chamaillard M., Labigns A., Thomas G., Philpott D., Samsonetti P. J. Nod2 is a general sesor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003; 278: 8869–8872, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Glatt C. M., Smith C., Foster W., Ladics G. S. Differentiation between sensitizers and irritants in the local lymph node assay using a minimal transcript set. Toxicol. Sci. 2003; 72(S-1)A1285, [CSA]
- Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in the elicitation of allergic contact hypersensitivity. Immunol. Today 1998; 19: 37–44, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Graham K. L., Robinson W. H., Steinman L., Utz P. J. High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases. Autoimmunity 2004; 37: 269–272, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Greenhalgh C. J., Metcalf D., Thaus A. L., Corbin J. E., Uren R., Morgan P. O., Fabri L. J., Zhang H. G., Martin H. M., Willson T. A., Billestrup N., Nicola N. A., Baca M., Alexander W. S., Hilton D. J. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 2002; 277: 40181–40184, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hayden M. S. Pharmacogenomics and infectious diseases: Impact on drug response and applications to disease management. Am. H. Health—Syst. Pharm. 2002; 59: 1626–1631, [CSA]
- Heller R. A., Schena M., Chai A., Shalon D., Bedilion T., Gilmore J., Woolley D. E., Davis R. W. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl. Acad. Sci. USA 1997; 94: 2150–2155, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hjelmervik T. O., Petersen K., Jonassen I., Jonsson R., Bolstad A. I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 2005; 52: 1534–1544, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hosford D. A., Lai E. H., Riley J. H., Xu C. F., Danoff T. M., Roses A. D. Pharmacogenetics to predict drug-related adverse events. Toxicol. Pathol 2004; 32(1)9–12, Suppl[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hulette B. C., Ryan C. A., Gerberick G. F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol. Appl. Pharmacol. 2002; 182: 226–233, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hung S. I., Chung W. H., Liou L. B., Chu C. C., Lin M., Huang H. P., Lin Y. L., Lan J. L., Yang L. C., Hong H. S., Chen M. J., Lai P C., Wu M. S., ChuYl C., Wang K. H., Chen C. H., Fann C. S., Wu J. Y., Chen Y. T. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl. Acad. Sci. USA 2005; 102: 4134–4139, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hutton J. J., Jegga A. G., Kong S., Gupta A., Ebert C., Williams S., Katz J. D., Aronow B. J. microarray and comparative genomics-based identification of genes and gene regulatory regions of the nouse immune system. BMC Genomics 2004; 5: 82–97, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Inohara N., Ogura Y., Fontalba A., Guttierez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S. J., Moran A. P., Fernandez-Luna J. L., Nunez G. host recognition of bacterial muramyl dipeptide is mediatd through NOD2: Impoications for Crohn's disease. J. Biol. Chem. 2003; 278: 5509–5512, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kamoi H., Kanazawa H., Hirata K., Kurihara N., Yano Y., Otani S. Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. 1995; 211: 1031–1035, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaplowitz N. Drug-induced liver injury. Clin. Infect. Dis 2004; 38(Suppl. 2)S44–S48, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nature Rev. (Drug Discovery) 2005; 4: 489–499, [CROSSREF], [CSA]
- Kimber I., Basketter D. A., Butler M., Gamer A., Garrigue J-L., Gerberick G. F., Newsome C., Steiling W., Vohr H-W. Classification of contact allergens according to potency: Proposals. Fd. Chem. Toxic. 2003; 41: 1799–1809, [CROSSREF], [CSA]
- Kimber I., Basketter D. A., Gerberick G. F., Dearman R. J. Allergic contact dermatitis. Int. Immunopharmacol. 2002; 2: 201–211, [CROSSREF], [CSA]
- Kimber I., Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol. Appl. Pharmacol. 1992; 117: 137–146, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kimber I., Cumberbatch M., Betts C. J., Dearman R. J. Dendritic cells and skin sensitisation hazard assessment. Toxic. In Vitro 2004; 18: 195–202, [CROSSREF], [CSA]
- Kimber I., Cumberbatch Dearman R. J., Bhushan M., Griffiths C. E. M. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br. J. Dermatol. 2000; 142: 401–412, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kimber I., Dearman R. J. Allergic contact dermatitis: The cellular effectors. Contact Derm. 2002; 46: 1–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kimber I., Dearman R. J., Cumberbatch M., Huby R. J. D. Langerhans cells and chemical allergy. Curr. Opinion Immunol. 1998; 10: 614–619, [CROSSREF], [CSA]
- Kimber I., Pichowski J. S., Betts C. J., Cumberbatch M., Basketter D. A., Dearman R. J. Alternative approaches to the identification and characterization of chemical allergens. Toxic. In Vitro 2001; 15: 307–312, [CROSSREF], [CSA]
- Kinser S., Jia Q., Li M., Laughter A., Cornwell P., Corton J. C., Pestka J. Gene expression profiling in spleens of deoxynivalenol-exposed mice: Immediate early genes as primary targets. J. Toxicol. Environ. Health A 2004; 67: 1423–1441, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Klein T. W., Newton C., Zhu W., Daaka Y., Friedman H. Δ 9-Tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Proc. Soc. Exp. Biol. Med 1995; 209: 205–212, [PUBMED], [INFOTRIEVE], [CSA]
- Klein T. W., Lane B., Newton C. A., Friedman H. The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med. 2000; 225: 1–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Krenn V., Petersen I., Haupl T, Koepenik A., Blind C., Dietel M., Konthur Z., Skriner K. Array technology and proteomics in autoimmune diseases. Pathol. Res. Pract 2004; 200: 95–103, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lard L. R., van Gaalen F. A., Schonkeren J. J., Pieterman E. J., Stoeken G., Vos K., Nelissen R. G., Westendorp R. G., Hoeben R. C., Breedveld F. C., Toes R. E., Huizinga T. W. Association of the −2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. Arthritis Rheum. 2003; 48: 1841–1848, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laughter A. R., Dunn C. S., Swanson C. L., Howroyd P., Cattley R. C., Corton J. D. Role of the peroxisome proliferators-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver. Toxicology 2004; 203: 83–98, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367–377, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S. J., Oksenberg J. R., Raine C. S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002; 8: 500–508, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Luster M. I., Portier C., Pait D. G., Rosenthal G. J., Germolec D. R., Corsini E., Blaylock B. L., Pollock P., Kouchi Y., Craig W., White K. L., Munson A. E., Comment C. E. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol 1993; 21: 71–82, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Luyendyk J. P., Mattes W. B., Burgoon L. D., Zacharewski T. R., Maddox J. F., Cosma G. N., Ganey P. E., Roth R. A. Gene expression analysis points to hemostasis in livers of rats cotreated with lipopolysaccharide and ranitidine. Toxicol. Sci. 2004; 80: 203–213, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Luzina I. G., Atamas S. P., Wise R., Wigley F. M., Xiao H. Q., White B. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am. J. Respir. Cell. Mol. Biol. 2002; 26: 549–557, [PUBMED], [INFOTRIEVE], [CSA]
- Maas K., Chan S., Parker J., Slater A., Moore J., Olsen N., Aune T. M. Cutting edge: Molecular portrait of human autoimmune disease. J. Immunol 2002; 169: 5–9, [PUBMED], [INFOTRIEVE], [CSA]
- Maecker B., von Bergwelt-Baildon Anderson K.S., Vonderheide R. H., Schultze J. L. Linking genomics to immunotherapy by reverse immunology—‘immunomics’ in the new millennium. Curr. Mol. Med. 2001; 1: 609–619, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mahler M., Kessenbrock K., Raats J., Williams R., Fritzler M. J., Bluthner M. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J. Mol. Med. 2003; 81: 194–204, [PUBMED], [INFOTRIEVE], [CSA]
- Martin A. M., Nolan D., Gaudieri S., Almeida C. A., Nolan R., James I., Carvalho F., Phillips E., Christiansen F. T., Purcell A. W., McCluskey J., Mallal S. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl. Acad. Sci. USA. 2004; 101: 4180–4185, [PUBMED], [INFOTRIEVE], [CSA]
- Martin A. M., Nolan D., James I., Cameron P., Leller J., Moore C., Phillips E., Christiansen F. T., Mallal S. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. AIDS 2005; 19: 9–99, [CSA]
- Martin W., Sbai H., De Groot A. S. Bioinformatics tools for identifying class I-restricted epitopes. Methods 2003; 29: 289–298, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mattes W. B., Pettit S. D., Sansone S.-A., Bushel P. R., Waters M. D. Database development in toxicogenomics: Issues and efforts. Environ. Health Perspect 2004; 112(4)495–505, [PUBMED], [INFOTRIEVE], [CSA]
- McDonald H. R., Bommhardt U., Cerrottini J. C. Developmentally regulated expression of P-glycoprotein (multidrug resistance) activity in mouse thymocytes. Eur. J. Immunol. 1995; 25: 1457–1460, [CSA]
- McKallip R. J., Lombard C., Fisher M., Martin B. R., Ryu S., Grant S., Nagarkatti M., Nagarkatti P. S. Targeting CB2 cannabinoid receptors as a noveltherapty to treat malignant lymphblastic disease. Blood 2002; 100: 627–634, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McKallip R. J., Nagarkatti M., Nagarkatti P. S. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol. 2005; 174: 3281–3289, [PUBMED], [INFOTRIEVE], [CSA]
- Metcalf D., Greenhalgh C. J., Viney E., Willson T. A., Starr R., Nicola N. A., Hilton D. J., Alexander W. S. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 2000; 405: 1069–1073, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mocellin S., Wang E., Panelli M., Pilati P., Marincola F. M. DNA array-based gene profiling in tumor immunology. Clin. Cancer Res. 2004; 10: 4597–4606, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Morahan G., Morel L. Genetics of autoimmune diseases in humans and in animal models. Curr. Opin. Immunol. 2002; 14: 803–811, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mosca P. J., Lyerly H. K., Ching C. D., Hobeika A. C., Clay T. M., Morse M. A. Proteomics for monitoring immune responses to cancer vaccines. Curr. Opin. Molec. Therap. 2003; 5: 39–43, [CSA]
- Nau G. J., Richmond J. F., Schlesinger A., Jennings E. G., Lander E. S., Young R. A. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 2002; 99: 1503–1508, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ng B., Yang F., Huston D. P., Yan Y., Yang Y., Xiong Z., Peterson L. E., Wang H., Yang X. F. Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J. Allergy Clin. Immunol. 2004; 114: 1463–1470, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Oestreicher J. L., Walters I. B., Kikuchi T., Gilleaudeau P., Surette J., Schwertschlag U., Dorner A. J., Krueger J. G., Trepicchio W. L. Molecular classification of psoriasis disease-associated genes through pharmacogenomics expression profiling. Pharmacogenomics J. 2001; 1: 272–287, [PUBMED], [INFOTRIEVE], [CSA]
- Padyukov L., Hytonen A. M., Smolnikova M., Hahn-Zoric M., Nilsson N., Hanson L. A., Tarkowski A., Klareskog L. Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J. Rheumatol. 2004; 31: 422–425, [PUBMED], [INFOTRIEVE], [CSA]
- Patterson R. M., Walker N., Baker S., Dickinson T., White K., Musgrove D., Harrsion S., Germolec D. R. Gene expression alterations in immune system pathways following exposure to immunosuppressive chemicals. The Toxicologist March, 2005; 73, [CSA]
- Paxton W. A., Kang S. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Seminars Immunol. 1998; 10: 187–194, [CROSSREF], [CSA]
- Pennie W. D., Kimber I. Toxicogenomics: Transcript profiling and potential application to chemical allergy. Toxicol. In Vitro 2002; 16: 319–326, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Peters S. P. Asthma treatment in the 21st century—what's next?. Clin. Rev. Allergy Immunol 2004; 27: 197–205, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Phillips E. J., Wong G. A., Kaul R., Shahabi K., Nolan D. A., Knowles S. R., Martin A. M., Mallal S. A., Shear N. H. AIDS 2005; 10: 979–981, [CSA]
- Pichowski J. S., Cumberbatch M., Dearman R. J., Basketter D. A., Kimber I. Investigation of induced changes in interleukin 1β m RNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicol. In Vitro 2000; 14: 351–360, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pichowski J. S., Cumberbatch M., Dearman R. J., Basketter D. A., Kimber I. Allergen-induced changes in interleukin 1β (IL-1β) mRNA expression by human blood-derived dendritic cells: Inter-individual differences and relevance for sensitization testing. J. Appl. Toxicol. 2001; 21: 115–121, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pirmohamed M., Back D. J. The pharmacogenomics of HIV therapy. Pharmacogenomics J. 2001; 1: 243–253, [PUBMED], [INFOTRIEVE], [CSA]
- Pruett S. B., Schwab C., Zheng Q., Fan R. Suppression of innate immunity by acute ethanol administration: A global perspective and a new mechanism beginning with inhibition of signaling through toll-like receptor 3. J. Immunol. 2004; 173: 2715–2724, [PUBMED], [INFOTRIEVE], [CSA]
- Pulendran B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 2005; 174: 2457–2465, [PUBMED], [INFOTRIEVE], [CSA]
- Reutter K., Jager D., Degwert J., Hoppe U. In vitro model for contact sensitization. II Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitizers. Toxicol. In Vitro 1997; 11: 619–626, [CROSSREF], [CSA]
- Reveille J. D. Genetic studies in the rheumatic diseases: Present status and implications for the future. J. Rheumatol. Suppl. 2005; 72: 10–13, [PUBMED], [INFOTRIEVE], [CSA]
- Robinson W. H., DiGennaro C., Hueber W., Haab B. B., Kamachi M., Dean E. J., Fournel S., Fong D., Genovese M. C., de Vegvar H. E., Skriner K., Hirschberg D. L., Morris R. I., Muller S., Pruijn G. J., van Venrooij W. J., Smolen J. S., Brown P. O., Steinman L., Utz P. J. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002a; 8: 295–301, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Robinson W. H., Garren H., Utz P. J., Steinman L. Proteomics for the development of DNA tolerizing vacines to treat autoimmune disease. Clin. Immunol. 2002b; 103: 7–12, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Robinson W. H., Steinman L., Utz P. J. Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics 2003; 3: 2077–2084, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Romani N., Gruner S., Brang D., Lampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinman R. M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994; 180: 83–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roth M. D., Baldwin G. C., Tashkin D. P. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem. Phys. Lipids. 2002; 121: 229–239, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rus V., Atamas S. P., Shustova V., Luzina I. G., Selaru F., Magder L. S., Via C. S. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin. Immunol. 2002; 102: 283–290, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ryan C. A., Hulette B. C., Gerberick G. F. Approaches for the development of cell-based in vitro methods for contact sensitization. Toxic. In Vitro 2001; 15: 43–55, [CROSSREF], [CSA]
- Ryan C. A., Gildea L. A., Hulette B. C., Dearman R. J., Kimber I., Gerberick G. F. Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicol. Lett. 2004a; 150: 301–316, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ryan C. A., Hulette B. C., Gildea L. A., Dearman R. J., Kimber I., Gerberick G. F. Examination of phenotypic changes in peripheral blood-derived dendritic cells following exposure to a contact allergen: Cell surface marker and gene expression. J. Toxicol. Cut Ocular Toxicol. 2004b; 23: 91–104, [CROSSREF], [CSA]
- Ryan C. A., Gerberick G. F., Gildea L. A., Hulette B. C., Betts C. J., Cumberbatch M. C., Dearman R. J., Kimber I. Interactions of contact allergens with dendritic cells: Opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol. Sci. 2005, (in press)[CSA]
- Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 1994; 179: 1109–1118, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sanchez C., Galve-Roperh I., Canova C., Brachet P., Guzman M. Δ 9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 1998; 436: 6–10, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sanchez C., de Ceballos M. L., del Pulgar T. G., Rueda D., Corbacho C., Velasco G., Galve-Roperh I., Huffman J. W., Ramon Y. C. S., Guzman M. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res. 2001; 61: 5784–5789, [PUBMED], [INFOTRIEVE], [CSA]
- Selak S., Chan E. K., Schoenroth L., Senecal J. L., Fritzler M. J. Early endosome antigen. 1: An autoantigen associated with neurological diseases. J. Investig. Med. 1999; 47: 311–318, [PUBMED], [INFOTRIEVE], [CSA]
- Selak S., Mahler M., Miyachi K., Fritzler M. L., Fritzler M. J. Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1). Clin. Immunol. 2003; 109: 154–164, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Selgrade M. K. Use of immunotoxicity data in health risk assessments: Uncertainties and research to improve the process. Toxicology 1999; 133: 59–72, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sette A., Fleri W., Peters B., Sathiamurthy M., Bui H. H., Wilson S. A roadmap for the immunomics of category A-C pathogens. Immunity 2005; 22: 155–161, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shaffer A. L., Rosenwald A., Hurt E. M., Giltnane J. M., Lam L. E., Pickeral O. K., Staudt L. M. Immunity 2001; 15: 375–385, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shen N., Tsao B. P. Current advances in the human lupus genetics. Curr. Rheumatol. Rep. 2004; 6: 391–398, [PUBMED], [INFOTRIEVE], [CSA]
- Smith M. T., Vermeulen R., Li G., Zhang L., Lan Q., Hubbard A. E., Forrest M. S., McHale C., Zhao X., Gunn L., Shen M., Rappaport S. M., Yin S., Chanock S., Rothman N. Use of ‘omic’ technologies to study humans exposed to benzene. Chem. Biol. Interact 2005; 153–154: 123–127, [CROSSREF], [CSA]
- Sharova L. V., Gogal R. M., Jr., Sharov A. A., Chrisman M. V., Holladay S. D. Immune stimulation in urethane-exposed pregnant mice increases expression level of spleen leukocyte genes for TGFbeta3 GM-CSF and other cytokines that may play a role in reduced chemical-induced birth defects. Int. Immunopharmacol. 2002; 2: 1477–1489, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sharova L. V., Sharov A. A., Sura P., Gogal R. M., Jr., Smith B. J., Holladay S. D. Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: Are these events related to reduced teratogenesis?. Int. Immunopharmacol. 2002; 3: 945–955, [CROSSREF], [CSA]
- Staudt L. M., Brown P. O. Genomic views of the immune system. Annu. Rev. Immunol. 2000; 18: 829–859, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tedder T. F., Engel P. CD20: A regulator of cell-cycle progression of B lymphocytes. Immunol. Today 1994; 15: 450–454, [PUBMED], [INFOTRIEVE], [CSA]
- Tuschl H., Kovac R. Langerhans cells and immature dendritic cells as model systems for screening skin sensitizers. Toxicol. In Vitro 2001; 15: 327–331, [PUBMED], [INFOTRIEVE], [CSA]
- Tsuchl H., Kovac R., Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 2000; 14: 541–549, [CROSSREF], [CSA]
- Utrecht J. Prediction of a new drug's potential to cause idiosyncratic reactions. Curr. Opin. Drug Disc. Dev. 2001; 4: 55–59, [CSA]
- Utrecht J. Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. Drug Disc. Today 2003; 8: 832–837, [CROSSREF], [CSA]
- van d er, Pouw Kraan T. C., van Gaalen F. A., Huizinga T. W., Pieterman E., Breedveld F. C., Verweij C. L. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: Evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun. 2003; 4: 187–196, [CROSSREF], [CSA]
- van d er, Pouw Kraan T. C., Kasperkovitz P. V., Verbeet N., Verweij C. L. Genomics in the immune system. Clin. Immunol. 2004; 111: 175–185, [CROSSREF], [CSA]
- Wang Z., Neuburg D., Li C., Su L., Kim J. Y., Chen J. C., Christiani D. C. Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ. Health Perspect. 2005; 113: 233–241, [PUBMED], [INFOTRIEVE], [CSA]
- Wu M. M., Chiou H. Y., Ho I. C., Chen C. J., Lee T. C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ. Health Perspect. 2003; 111: 1429–1438, [PUBMED], [INFOTRIEVE], [CSA]
- Wu R., Zhou M., Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept. 2003; 112: 19–26, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhou X., Tan F. K., Xiong M., Milewicz D. M., Feghali C. A., Fritzler M. J., Reveille J. D., Arnett F. C. Systemic sclerosis (scleroderma): Specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J. Immunol. 2001; 167: 7126–7133, [PUBMED], [INFOTRIEVE], [CSA]
- Zhu M., John S., Berg M., Leonard W. J. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell 1999; 96: 121–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]